164 related articles for article (PubMed ID: 35844751)
1. Plasma Signaling Factors in Patients With Langerhans Cell Histiocytosis (LCH) Correlate With Relative Frequencies of LCH Cells and T Cells Within Lesions.
Mitchell J; Kvedaraite E; von Bahr Greenwood T; Lourda M; Henter JI; Berzins SP; Kannourakis G
Front Pediatr; 2022; 10():872859. PubMed ID: 35844751
[TBL] [Abstract][Full Text] [Related]
2. Foxp3
Mitchell J; Kelly J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Clin Immunol; 2020 Jun; 215():108418. PubMed ID: 32283322
[TBL] [Abstract][Full Text] [Related]
3. Activated Conventional T-Cells Are Present in Langerhans Cell Histiocytosis Lesions Despite the Presence of Immune Suppressive Cytokines.
Quispel WT; Stegehuis-Kamp JA; Santos SJ; Egeler RM; van Halteren AG
J Interferon Cytokine Res; 2015 Oct; 35(10):831-9. PubMed ID: 26381039
[TBL] [Abstract][Full Text] [Related]
4. Morphoproteomics provides support for TGF-β pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis.
Alexandrescu S; Tatevian N; Czerniak BA; Covinsky MH; Burns NK; Brown RE
Int J Clin Exp Pathol; 2012; 5(6):503-11. PubMed ID: 22949932
[TBL] [Abstract][Full Text] [Related]
5. Altered Populations of Unconventional T Cell Lineages in Patients with Langerhans Cell Histiocytosis.
Mitchell J; Kvedaraite E; von Bahr Greenwood T; Henter JI; Pellicci DG; Berzins SP; Kannourakis G
Sci Rep; 2018 Nov; 8(1):16506. PubMed ID: 30405183
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
7. A potentially important role for T cells and regulatory T cells in Langerhans cell histiocytosis.
Mitchell JM; Berzins SP; Kannourakis G
Clin Immunol; 2018 Sep; 194():19-25. PubMed ID: 29928999
[TBL] [Abstract][Full Text] [Related]
8. Does CD1a Expression Influence T Cell Function in Patients With Langerhans Cell Histiocytosis?
Mitchell J; Kannourakis G
Front Immunol; 2021; 12():773598. PubMed ID: 34956202
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characterization of immune cell infiltration in paediatric and adult Langerhans cell histiocytosis.
Paredes SEY; Almeida LY; Trevisan GL; Polanco XBJ; Silveira HA; Vilela Silva E; Segato RAB; da Silva LAB; Chahud F; León JE
Scand J Immunol; 2020 Dec; 92(6):e12950. PubMed ID: 32738155
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis.
Morimoto A; Oh Y; Nakamura S; Shioda Y; Hayase T; Imamura T; Kudo K; Imashuku S;
Cytokine; 2017 Sep; 97():73-79. PubMed ID: 28582647
[TBL] [Abstract][Full Text] [Related]
11. Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.
Senechal B; Elain G; Jeziorski E; Grondin V; Patey-Mariaud de Serre N; Jaubert F; Beldjord K; Lellouch A; Glorion C; Zerah M; Mary P; Barkaoui M; Emile JF; Boccon-Gibod L; Josset P; Debré M; Fischer A; Donadieu J; Geissmann F
PLoS Med; 2007 Aug; 4(8):e253. PubMed ID: 17696642
[TBL] [Abstract][Full Text] [Related]
12. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Egeler RM; Favara BE; van Meurs M; Laman JD; Claassen E
Blood; 1999 Dec; 94(12):4195-201. PubMed ID: 10590064
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T-cell expansion in oral and maxillofacial Langerhans cell histiocytosis.
Zhang C; Gao J; He J; Liu C; Lv X; Yin X; Deng Y; Lu Z; Tian Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):547-556. PubMed ID: 32988807
[TBL] [Abstract][Full Text] [Related]
14. The presence of cytokines in Langerhans' cell histiocytosis.
de Graaf JH; Tamminga RY; Dam-Meiring A; Kamps WA; Timens W
J Pathol; 1996 Dec; 180(4):400-6. PubMed ID: 9014861
[TBL] [Abstract][Full Text] [Related]
15. Apparent Lack of
Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
Front Immunol; 2019; 10():3045. PubMed ID: 31998317
[TBL] [Abstract][Full Text] [Related]
16. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis.
Kannourakis G; Abbas A
Br J Cancer Suppl; 1994 Sep; 23():S37-40. PubMed ID: 8075004
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis.
Murakami I; Matsushita M; Iwasaki T; Kuwamoto S; Kato M; Nagata K; Horie Y; Hayashi K; Imamura T; Morimoto A; Imashuku S; Gogusev J; Jaubert F; Takata K; Oka T; Yoshino T
Cell Commun Signal; 2015 Feb; 13():13. PubMed ID: 25889448
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the Treatment of Adult Langerhans Cell Histiocytosis --Review].
Tian ZZ; Cui YJ; Peng HL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):970-974. PubMed ID: 35680836
[TBL] [Abstract][Full Text] [Related]
19. High levels of plasma interleukin-17A are associated with severe neurological sequelae in Langerhans cell histiocytosis.
Ismail MB; Åkefeldt SO; Lourda M; Gavhed D; Aricò M; Henter JI; Delprat C; Valentin H
Cytokine; 2020 Feb; 126():154877. PubMed ID: 31629106
[TBL] [Abstract][Full Text] [Related]
20. New insights into the molecular pathogenesis of langerhans cell histiocytosis.
Rizzo FM; Cives M; Simone V; Silvestris F
Oncologist; 2014 Feb; 19(2):151-63. PubMed ID: 24436311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
